NYMOX PHARMACEUTICAL CORP (NYMX)       0.38  +0.01 (+2.7%)

0.38  +0.01 (+2.7%)

BSP733981026 - Common Stock

News Image
14 days ago - Nymox Pharmaceutical Corporation

NYMOX Provides Current Update

IRVINE, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide a current update on business...

News Image
2 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!

News Image
2 months ago - Nymox Pharmaceutical Corporation

NYMOX Updates Shareholders

IRVINE, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced an update to its shareholders regarding...

News Image
2 months ago - Nymox Pharmaceutical Corporation

NYMOX Receives Deficiency Letter from NASDAQ

IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports that on July 7, 2022 the Company received a...

News Image
4 months ago - Nymox Pharmaceutical Corporation

NYMOX Receives RTF letter from FDA

IRVINE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today that it has received a Refusal to File...

News Image
5 months ago - Market News Video

Friday 5/6 Insider Buying Report: ALGN, NYMX

News Image
6 months ago - Nymox Pharmaceutical Corporation

Nymox Announces Closing of $6.4 Million Financing

IRVINE, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has...

News Image
6 months ago - Nymox Pharmaceutical Corporation

Nymox Announces $5 Million Registered Direct Offering

IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive...

News Image
7 months ago - Nymox Pharmaceutical Corporation

NYMOX Announces Submission of New Drug Application (NDA) to the FDA for Fexapotide Triflutate

IRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that it...